Platelet‐rich plasma ultrasound‐guided injection in the treatment of carpal tunnel syndrome: A placebo‐controlled clinical study

Platelet‐rich plasma ultrasound‐guided injection in the treatment of carpal tunnel syndrome:... The purpose of this study is to demonstrate whether and to what extent a single injection of platelet‐rich plasma (PRP), under ultrasound guidance, can improve the clinical symptoms of patients with a mild to moderate carpal tunnel syndrome (CTS). We conducted a prospective, randomized, clinical study including 50 patients suffering from mild to moderate CTS for a minimum duration of 3 months. Patients were randomly divided into 2 groups: Group A (26 patients) received an ultrasound‐guided PRP injection into the carpal tunnel, whereas Group B (24 patients) was injected with placebo (0.9% normal saline). The short‐ and mid‐term outcomes were determined with the use of the Q‐DASH questionnaire and the pain scale VAS administered at 0, 4, and 12 weeks follow‐up. The success ratio was determined by the difference in the Q‐DASH obtained pre‐injection minus the final Q‐DASH obtained after 12 weeks follow‐up. Success was defined as a difference more than 25%. Group A patients demonstrated a 76.9% success as determined by the difference Q‐DASH, whereas Group B patients demonstrated 33.3% success, which was significantly less than Group A (Χ2, p = .011). The findings of this study suggest that a single PRP ultrasound‐guided injection has positive effects in patients with CTS. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Tissue Engineering and Regenerative Medicine Wiley

Platelet‐rich plasma ultrasound‐guided injection in the treatment of carpal tunnel syndrome: A placebo‐controlled clinical study

Loading next page...
 
/lp/wiley/platelet-rich-plasma-ultrasound-guided-injection-in-the-treatment-of-Qf86IfCDtP
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 John Wiley & Sons, Ltd.
ISSN
1932-6254
eISSN
1932-7005
D.O.I.
10.1002/term.2566
Publisher site
See Article on Publisher Site

Abstract

The purpose of this study is to demonstrate whether and to what extent a single injection of platelet‐rich plasma (PRP), under ultrasound guidance, can improve the clinical symptoms of patients with a mild to moderate carpal tunnel syndrome (CTS). We conducted a prospective, randomized, clinical study including 50 patients suffering from mild to moderate CTS for a minimum duration of 3 months. Patients were randomly divided into 2 groups: Group A (26 patients) received an ultrasound‐guided PRP injection into the carpal tunnel, whereas Group B (24 patients) was injected with placebo (0.9% normal saline). The short‐ and mid‐term outcomes were determined with the use of the Q‐DASH questionnaire and the pain scale VAS administered at 0, 4, and 12 weeks follow‐up. The success ratio was determined by the difference in the Q‐DASH obtained pre‐injection minus the final Q‐DASH obtained after 12 weeks follow‐up. Success was defined as a difference more than 25%. Group A patients demonstrated a 76.9% success as determined by the difference Q‐DASH, whereas Group B patients demonstrated 33.3% success, which was significantly less than Group A (Χ2, p = .011). The findings of this study suggest that a single PRP ultrasound‐guided injection has positive effects in patients with CTS.

Journal

Journal of Tissue Engineering and Regenerative MedicineWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off